Skip to content

Physical Activity and Functioning in Home Dialysis Patients

Physical Activity and Functioning in Home Dialysis Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01602718
Enrollment
120
Registered
2012-05-21
Start date
2012-06-30
Completion date
2016-06-30
Last updated
2016-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

physical activity, physical performance, ESRD, home dialysis

Brief summary

This study will compare physical activity levels and physical functioning in patients treated with home dialysis vs. those treated with in-center dialysis. The investigators will first compare prevalent patients, and will also compare the two groups longitudinally in incident patients over the first 18 months of beginning the dialysis treatments. Patients will be tested for physical functioning using standard performance-based testing such as gait speed, chair stand, balance test, as well as self-reported limitations in activities of daily living. The investigators will monitor physical activity using step counters and activity questionnaires. Blood samples will be drawn at each testing time to measure inflammatory markers. A pilot study of home dialysis patients will be done to determine the effects of an independent home-based exercise program on physical functioning and inflammatory markers. For this pilot study, 30 patients will be randomized into exercise intervention and usual care with testing at baseline and again after 3 months of the intervention.

Detailed description

Aim 1: To determine levels of physical functioning, physical activity, incidence of frailty and inflammation status in prevalent home dialysis patients in the University of Utah Home Dialysis program and compare them to in-center hemodialysis patients who are matched for age, gender, comorbidities and dialysis vintage. Hypothesis 1: Patients on home therapies will have higher physical functioning, be more active and fewer will be frail compared to matched patients treated with in-center hemodialysis. Aim 2: To determine the patterns of change in physical functioning and physical activity over the first 18 months of initiating dialysis therapy. Hypothesis 2: Physical functioning and physical activity will be maintained in patients initiating home dialysis therapy, whereas, those initiating in-center dialysis will deteriorate in physical functioning and physical activity. Aim 3: To determine the effects of counseling and encouragement of physical activity in prevalent home dialysis patients on physical functioning, physical activity. Hypothesis 3: Compared to usual care, patients who are counseled and encouraged to participate in independent home walking exercise will improve physical functioning and health-related quality of life. Aim 4: To determine the association of inflammation with physical functioning in home dialysis patients and with changes in physical activity. Hypothesis 4: Lower physical functioning is associated with inflammation and increased physical activity will improve physical functioning and reduce the associated inflammation.

Interventions

OTHERexercise training

Pilot study of independent home exercise training (walking or cycling exercise plus low level resistance exercise) for 3 months. Patients will be given specific recommendations for type, frequency, duration and progression of their program and will be contacted weekly by study staff to assess progress and evaluation for any problems. This is a 3 month exercise training intervention in 15 subjects (and 15 no-exercise controls).

Sponsors

Baxter Healthcare Corporation
CollaboratorINDUSTRY
University of Utah
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* on dialysis for 3 months (for prospective study and for pilot intervention) * 18 years of age * ambulatory * no progressive neuromuscular disease * no orthopedic or rheumatologic problems that would be exacerbated by physical function testing * English speaking * able to understand and provide consent for participation

Exclusion criteria

* progressive neuromuscular disease that may result in limitations * orthopedic or rheumatologic disease that may be exacerbated by physical function testing * physical functioning * unstable angina or angina upon exertion * terminal illness with life expectancy less than 12 months * MI or CABG within the last year * NYHA Class III or IV CHF

Design outcomes

Primary

MeasureTime frame
change in short physical performance batterybaseline, 3 months, 6 months 12 mo, 18 mo

Secondary

MeasureTime frame
change in inflammationbaseline, 6 mo, 12 mo, 18 mo

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026